Form 4: Thermo Fisher CFO Gifts Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Thermo Fisher Scientific's Senior VP and CFO, Stephen Williamson, reported a gift of 433 shares of common stock under a Rule 10b5-1 plan.

Summary

  • Stephen Williamson, Senior VP and CFO of Thermo Fisher Scientific Inc., reported a disposition of 433 shares of common stock.
  • The transaction occurred on November 14, 2025, and was coded as a gift (G).
  • The shares were disposed of at a price of $0 per share.
  • Following this transaction, Stephen Williamson directly owns 31,887.193 shares and indirectly owns 12,674 shares through a SLAT.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged disposition strategy.

Sentiment

Score: 5

Explanation: Neutral, as it reports a routine insider transaction (a gift) under a pre-arranged plan, which is a common occurrence and not inherently positive or negative for the company's operational performance or financial health.

Positives

  • The transaction was executed under a Rule 10b5-1(c) plan, which demonstrates pre-planning and transparency, mitigating concerns about opportunistic insider trading.
  • The disposition was a gift, not a sale for personal cash proceeds, which can be viewed differently than a market sale.

Negatives

  • A disposition of shares, even as a gift, reduces the direct equity stake of a senior executive in the company, slightly decreasing their direct alignment with shareholder interests.

Future Outlook

NA

Management Comments

  • The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.

Industry Context

NA

Related Party Transactions

  • Indirect ownership of 12,674 shares through a SLAT (Spousal Lifetime Access Trust), with the reporting person disclaiming beneficial ownership except for pecuniary interest.

Stakeholder Impact

  • Minor impact on shareholders due to a small reduction in the executive's direct equity stake, but the transaction is a gift and not a sale for cash.
  • No direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
11/14/2025Date of common stock disposition by gift.
11/17/2025Date the Form 4 was signed and filed.

Recommendation

hold

The filing details a routine insider transaction (a gift of a relatively small number of shares) by a senior executive under a Rule 10b5-1 plan. This type of transaction is not indicative of the company's operational performance or future prospects and therefore does not warrant a change in investment recommendation based solely on this filing. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Thermo Fisher Scientific, TMO, Stephen Williamson, Form 4, Insider Transaction, Share Disposition, Gift, CFO, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.